Free Trial

Innospec (IOSP) Competitors

Innospec logo
$108.91
+0.52 (+0.48%)
(As of 11/4/2024 ET)

IOSP vs. LTHM, GCP, PQG, NGVT, GRA, BCPC, NEU, ASH, FUL, and SXT

Should you be buying Innospec stock or one of its competitors? The main competitors of Innospec include Livent (LTHM), GCP Applied Technologies (GCP), PQ Group (PQG), Ingevity (NGVT), W. R. Grace & Co. (GRA), Balchem (BCPC), NewMarket (NEU), Ashland (ASH), H.B. Fuller (FUL), and Sensient Technologies (SXT).

Innospec vs.

Innospec (NASDAQ:IOSP) and Livent (NYSE:LTHM) are both mid-cap basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, community ranking, profitability, institutional ownership, analyst recommendations, earnings and valuation.

Livent has lower revenue, but higher earnings than Innospec. Livent is trading at a lower price-to-earnings ratio than Innospec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innospec$1.89B1.43$139.10M$5.9718.24
Livent$813.20M3.65$273.50M$1.799.22

Livent has a consensus target price of $16.67, indicating a potential upside of 0.95%. Given Livent's higher possible upside, analysts plainly believe Livent is more favorable than Innospec.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innospec
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Livent
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67

Innospec has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Comparatively, Livent has a beta of 1.76, indicating that its stock price is 76% more volatile than the S&P 500.

In the previous week, Innospec had 2 more articles in the media than Livent. MarketBeat recorded 2 mentions for Innospec and 0 mentions for Livent. Innospec's average media sentiment score of 0.14 beat Livent's score of 0.00 indicating that Innospec is being referred to more favorably in the media.

Company Overall Sentiment
Innospec Neutral
Livent Neutral

96.6% of Innospec shares are held by institutional investors. Comparatively, 96.8% of Livent shares are held by institutional investors. 1.5% of Innospec shares are held by company insiders. Comparatively, 1.2% of Livent shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Innospec received 208 more outperform votes than Livent when rated by MarketBeat users. Likewise, 65.93% of users gave Innospec an outperform vote while only 50.21% of users gave Livent an outperform vote.

CompanyUnderperformOutperform
InnospecOutperform Votes
329
65.93%
Underperform Votes
170
34.07%
LiventOutperform Votes
121
50.21%
Underperform Votes
120
49.79%

Livent has a net margin of 40.77% compared to Innospec's net margin of 7.90%. Livent's return on equity of 25.60% beat Innospec's return on equity.

Company Net Margins Return on Equity Return on Assets
Innospec7.90% 14.15% 9.75%
Livent 40.77%25.60%18.40%

Summary

Innospec and Livent tied by winning 8 of the 16 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IOSP vs. The Competition

MetricInnospecChemicals & allied products IndustryMaterials SectorNASDAQ Exchange
Market Cap$2.72B$4.25B$2.80B$8.43B
Dividend Yield1.41%2.75%5.23%4.16%
P/E Ratio18.2419.66122.6516.71
Price / Sales1.4334.78554,321.9876.32
Price / Cash13.9810.8323.4733.56
Price / Book2.363.543.584.98
Net Income$139.10M$244.61M$145.49M$224.69M
7 Day Performance-0.34%2.70%-0.98%-0.51%
1 Month Performance-3.00%-2.10%0.77%3.32%
1 Year Performance8.53%20.36%30.09%25.51%

Innospec Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IOSP
Innospec
3.4834 of 5 stars
$108.91
+0.5%
N/A+8.5%$2.70B$1.95B18.242,400
LTHM
Livent
N/A$16.51
flat
$19.80
+19.9%
N/A$2.97B$813.20M9.221,350
GCP
GCP Applied Technologies
0.2769 of 5 stars
$32.01
flat
N/AN/A$2.37B$970.10M228.641,800News Coverage
PQG
PQ Group
N/AN/AN/AN/A$2.14B$1.11B-10.872,274
NGVT
Ingevity
2.6145 of 5 stars
$41.65
+17.9%
$51.00
+22.4%
-2.1%$1.51B$1.69B-3.501,700Earnings Report
High Trading Volume
GRA
W. R. Grace & Co.
1.5285 of 5 stars
$69.99
flat
N/AN/A$4.64B$1.73B60.344,000Analyst Forecast
BCPC
Balchem
4.5772 of 5 stars
$168.88
-0.2%
$185.00
+9.5%
+42.5%$5.48B$932.39M47.041,302Analyst Forecast
NEU
NewMarket
3.3053 of 5 stars
$531.67
-1.1%
N/A+7.0%$5.10B$2.78B12.412,000Positive News
ASH
Ashland
4.5269 of 5 stars
$87.15
+0.7%
$103.50
+18.8%
+9.9%$4.26B$2.11B29.543,800Upcoming Earnings
FUL
H.B. Fuller
4.4618 of 5 stars
$74.57
-0.3%
$97.67
+31.0%
+4.8%$4.07B$3.55B23.027,200
SXT
Sensient Technologies
3.9879 of 5 stars
$77.28
-1.4%
$85.00
+10.0%
+28.4%$3.27B$1.53B36.983,956

Related Companies and Tools


This page (NASDAQ:IOSP) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners